TIM-3 and its ligand, galectin-9 (Gal-9), constitute an autocrine loop which drives the self-renewal of AML stem cells by activating the nuclear factor-κB (NF-κB) and β-catenin pathways (11). This evidence concerns the gene HAVCR2 and acute myeloid leukemia.